集團(tuán)簡(jiǎn)介  <br><br>  集團(tuán)簡(jiǎn)介 <br><br>廣州市清平集團(tuán)有限公司以醫(yī)藥、市場(chǎng)建設(shè)、科研、房地產(chǎn)開(kāi)發(fā)為主，兼營(yíng)進(jìn)出口貿(mào)易、餐飲業(yè)和三高農(nóng)業(yè)，具有豐富的市場(chǎng)運(yùn)作能力和先進(jìn)的科學(xué)管理經(jīng)驗(yàn)，擁有國(guó)內(nèi)外覆蓋能力較強(qiáng)的銷(xiāo)售網(wǎng)絡(luò)，是實(shí)力雄厚的大型現(xiàn)代化企業(yè)集團(tuán)。<br><br>清平集團(tuán)是一個(gè)多元化企業(yè)，它的發(fā)展戰(zhàn)略是重點(diǎn)產(chǎn)業(yè)突出，兩翼產(chǎn)業(yè)互補(bǔ)。集團(tuán)建立了通過(guò)gmp認(rèn)證的現(xiàn)代化中成藥、西藥制藥基地和通過(guò)gsp認(rèn)證的營(yíng)銷(xiāo)體系，積極打造具有中藥材交易采購(gòu)中心、電子商務(wù)和信息查詢中心、醫(yī)藥批發(fā)配送中心、藥品檢驗(yàn)和鑒證中心以及國(guó)藥匯展中心等功能的國(guó)際化醫(yī)藥物流配送平臺(tái)，初步形成了集種植、科研、生產(chǎn)、貿(mào)易和配送為一體的現(xiàn)代醫(yī)藥產(chǎn)業(yè)鏈。其中，醫(yī)藥產(chǎn)業(yè)板塊的發(fā)展戰(zhàn)略是面向國(guó)內(nèi)外市場(chǎng)，以半合成手性藥物、生物工程藥物和現(xiàn)代中藥為基礎(chǔ)，以緩釋、控釋、透皮、靶向給藥等現(xiàn)代制劑技術(shù)為導(dǎo)向，以erp管理技術(shù)為手段，形成以抗腫瘤藥物、心腦血管藥物和抗糖尿病藥物為主產(chǎn)品群，并聯(lián)合國(guó)內(nèi)外強(qiáng)勢(shì)的專(zhuān)業(yè)研發(fā)機(jī)構(gòu)，共同打造集團(tuán)可持續(xù)發(fā)展的動(dòng)力源。<br><br>group introduction<br><br>guangzhou qingping group co.， ltd. is a large modern group， mainly for medicine， market construction， science research， real estate development， etc.， and covers as well import and export trade， foods and drinks， and 3-high agriculture， etc.， with rich market operation capability and advanced scientific management experiences， and strong sale network covering domestically and internationally.<br><br>qingping group is an enterprise with multiple elements. its development strategy is of noble key industry with two wings of complementation. the group has set up the bases of modern patent traditional chinese medicine， and western medicine production， and the marketing system， being passed gmp certification. it actively forms up the international medical goods circulation platform with the functions of traditional chinese medicine dealing and purchasing center， e-commerce and information consultant center， medical wholesale and circulation center， medical test and certification center， and national medical exhibition center， etc， building up the modern medical industrial chain of planting， scientific research， production， trade and circulation. and， among which， the development strategy of medical sector is for the domestic and foreign market， with the semi compound medicine， biological medicine， modern traditional chinese medicine as base， being directed by the modern preparation technologies of releasing， controlling， penetrating and targeting medicine， with erp management technology as method， and forming the main product group of anti cancer drugs， heart and brain blood vessel drugs， anti diabetic drugs， etc. it cooperates with domestic and foreign strong professional research and development institutes， for making energy for sustainable development of qingping group.